To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Single shot ISBPB vs patient-controlled interscalene infusion for analgesia in rotator cuff repair

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2019

Single shot ISBPB vs patient-controlled interscalene infusion for analgesia in rotator cuff repair

Vol: 8| Issue: 2| Number:78| ISSN#: 2564-2537
Study Type:Randomized Trial
OE Level Evidence:2
Journal Level of Evidence:N/A

Interscalene brachial plexus bolus block versus patient-controlled interscalene indwelling catheter analgesia for the first 48 hours after arthroscopic rotator cuff repair

J Shoulder Elbow Surg. 2018 Jul;27(7):1243-1250

Contributing Authors:
YS Kim JH Kim HJ Lee HJ Koh DK Kim KY Lee KH Kwon

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

154 patients scheduled for arthroscopic rotator cuff repair were randomized to either a single-shot interscalene brachial plexus block (ssISBPB). patient-controlled interscalene infusion analgesia (PCIA) postoperatively, or to a control group not administered additional analgesia. The purpose was to compare pain scores from 1 hour to 48 hours after surgery. There were marked differences in pain sc...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue